Connect with us

News

ADHD medication abuse in schools is a ‘wake-up call’ | CNN

Published

on

ADHD medication abuse in schools is a ‘wake-up call’ | CNN



CNN
 — 

At some middle and high schools in the United States, 1 in 4 teens report they’ve abused prescription stimulants for attention deficit hyperactivity disorder during the year prior, a new study found.

“This is the first national study to look at the nonmedical use of prescription stimulants by students in middle and high school, and we found a tremendous, wide range of misuse,” said lead author Sean Esteban McCabe, director of the Center for the Study of Drugs, Alcohol, Smoking and Health at the University of Michigan in Ann Arbor.

“In some schools there was little to no misuse of stimulants, while in other schools more than 25% of students had used stimulants in nonmedical ways,” said McCabe, who is also a professor of nursing at the University of Michigan School of Nursing. “This study is a major wake-up call.”

Nonmedical uses of stimulants can include taking more than a normal dose to get high, or taking the medication with alcohol or other drugs to boost a high, prior studies have found.

Advertisement

Students also overuse medications or “use a pill that someone gave them due to a sense of stress around academics — they are trying to stay up late and study or finish papers,” said pediatrician Dr. Deepa Camenga, associate director of pediatric programs at the Yale Program in Addiction Medicine in New Haven, Connecticut.

“We know this is happening in colleges. A major takeaway of the new study is that misuse and sharing of stimulant prescription medications is happening in middle and high schools, not just college,” said Camenga, who was not involved with the study.

Published Tuesday in the journal JAMA Network Open, the study analyzed data collected between 2005 and 2020 by Monitoring the Future, a federal survey that has measured drug and alcohol use among secondary school students nationwide each year since 1975.

In the data set used for this study, questionnaires were given to more than 230,000 teens in eighth, 10th and 12th grades in a nationally representative sample of 3,284 secondary schools.

Schools with the highest rates of teens using prescribed ADHD medications were about 36% more likely to have students misusing prescription stimulants during the past year, the study found. Schools with few to no students currently using such treatments had much less of an issue, but it didn’t disappear, McCabe said.

Advertisement

“We know that the two biggest sources are leftover medications, perhaps from family members such as siblings, and asking peers, who may attend other schools,” he said.

Schools in the suburbs in all regions of the United States except the Northeast had higher rates of teen misuse of ADHD medications, as did schools where typically one or more parent had a college degree, according to the study.

Schools with more White students and those who had medium levels of student binge drinking were also more likely to see teen abuse of stimulants.

On an individual level, students who said they had used marijuana in the past 30 days were four times as likely to abuse ADHD medications than teens who did not use weed, according to the analysis.

In addition, adolescents who said they used ADHD medications currently or in the past were about 2.5% more likely to have misused the stimulants when compared with peers who had never used stimulants, the study found.

Advertisement

“But these findings were not being driven solely by teens with ADHD misusing their medications,” McCabe said. “We still found a significant association, even when we excluded students who were never prescribed ADHD therapy.”

Data collection for the study was through 2020. Since then, new statistics show prescriptions for stimulants surged 10% during 2021 across most age groups. At the same time, there has been a nationwide shortage of Adderall, one of the most popular ADHD drugs, leaving many patients unable to fill or refill their prescriptions.

The stakes are high: Taking stimulant medications improperly over time can result in stimulant use disorder, which can lead to anxiety, depression, psychosis and seizures, experts say.

If overused or combined with alcohol or other drugs, there can be sudden health consequences. Side effects can include “paranoia, dangerously high body temperatures, and an irregular heartbeat, especially if stimulants are taken in large doses or in ways other than swallowing a pill,” according to the Substance Abuse and Mental Health Services Administration.

Research has also shown people who misuse ADHD medications are highly likely to have multiple substance use disorders.

Advertisement

Abuse of stimulant drugs has grown over the past two decades, experts say, as more adolescents are diagnosed and prescribed those medications — studies have shown 1 in every 9 high school seniors report taking stimulant therapy for ADHD, McCabe said.

For children with ADHD who use their medications appropriately, stimulants can be effective treatment. They are “protective for the health of a child,” Camenga said. “Those adolescents diagnosed and treated correctly and monitored do very well — they have a lower risk of new mental health problems or new substance use disorders.”

The solution to the problem of stimulant misuse among middle and high school teens isn’t to limit use of the medications for the children who really need them, McCabe stressed.

“Instead, we need to look very long and hard at school strategies that are more or less effective in curbing stimulant medication misuse,” he said. “Parents can make sure the schools their kids attend have safe storage for medication and strict dispensing policies. And ask about prevalence of misuse — that data is available for every school.”

Families can also help by talking to their children about how to handle peers who approach them wanting a pill or two to party or pull an all-night study session, he added.

Advertisement

“You’d be surprised how many kids do not know what to say,” McCabe said. “Parents can role-play with their kids to give them options on what to say so they are ready when it happens.”

Parents and guardians should always store controlled medications in a lockbox, and should not be afraid to count pills and stay on top of early refills, he added.

“Finally, if parents suspect any type of misuse, they should contact their child’s prescriber right away,” McCabe said. “That child should be screened and assessed immediately.”

Advertisement

News

Read the Letter to the Inspectors General

Published

on

Read the Letter to the Inspectors General

Your investigation of these allegations is consistent with the IG’s mission to prevent waste, fraud, and abuse in federal agencies, and can help determine if politically connected crypto interests are undermining our national security. As Congress considers legislation on the market structure for digital assets, we must ensure that cryptocurrencies like USD1 are not providing the President and senior officials with the ability to line their pockets at the expense of the public interest.

The following facts have been reported in multiple outlets regarding Mr. Witkoff:

• Mr. Witkoff’s son Zach Witkoff is the CEO of World Liberty Financial (WLF), which the President’s family owns a majority stake in.³
• Beginning in January, one of Sheikh Tahnoon’s employees, Fiacc Larkin, joined WLF as the “chief strategic advisor” while continuing to work at G42, an AI investment firm owned by Sheikh Tahnoon that, according to the U.S. intelligence community, works closely with Chinese military companies.4



On May 1, 2025, Zach Witkoff announced that MGX, a state-owned investment firm controlled by Sheikh Tahnoon, had agreed to use a WLF-issued stablecoin, USD1, to make a $2 billion investment in Binance. As a result of this deal, WLF stands to reap hundreds of millions of dollars in transaction fees from MGX, and more from the returns on any investments it makes with the $2 billion deposit.³
As of August, Mr. Witkoff maintained a financial interest in WLF and thus stands to personally benefit from his son’s business dealings with the UAE.6 Nevertheless, he did not recuse himself from deliberations regarding the UAE, which may violate federal ethics law.

The following facts have been reported about Mr. Sacks:







He is a special government employee who continues to serve as a “general partner” at his venture capital fund, Craft Ventures.

8

The Abu Dhabi Investment Authority, an Emirati sovereign wealth fund controlled by Sheikh Tahnoon, was an early investor in Craft Ventures and continues to hold an investment in the fund.
In addition, Craft Ventures is invested in BitGo, which has partnered with WLF to provide the technical infrastructure for USD1. If BitGo’s valuation grows, based on the UAE’s investment into USD1, Mr. Sacks and his firm stand to benefit.

3 Yahoo Finance, “Trump family reportedly has a 60% stake in the World Liberty Financial,” Anand Sinha, March 31, 2025,
https://finance.yahoo.com/news/trump-family-reportedly-60-stake-172742661.html.
4 New York Times, “Inside U.S. Efforts to Untangle an A.I. Giant’s Ties to China,” Mark Mazzetti and Edward
Wong, Nov. 27, 2023, www.nytimes.com/2023/11/27/us/politics/ai-us-uae-china-security-g42.html.
5 New York Times, “At a Dubai Conference, Trump’s Conflicts Take Center Stage,” David Yaffe-Bellany, May 1, 2025, https://www.nytimes.com/2025/05/01/us/politics/trump-cryptocurrency-usd1-dubai-conference-

announcement.html.

6U.S Office of Government Ethics, Form 278e for Steven C. Witkoff, August 13, 2025, p. 23, https://static01.nyt.com/newsgraphics/documenttools/090d0de07e1d2fdf/bbf02867-full.pdf.

18 U.S.C. § 208.

8 White House, “Limited Waiver Pursuant to 18 U.S.C. § 208(b)(1) Regarding A.I. Assets,” June 2025,
https://www.whitehouse.gov/wp-content/uploads/2025/06/David-Sacks.pdf.

2

Continue Reading

News

Farage refuses to criticise Trump over paracetamol despite health experts dismissing autism claims

Published

on

Farage refuses to criticise Trump over paracetamol despite health experts dismissing autism claims

Nigel Farage has refused to criticise Donald Trump’s claims that paracetamol, sold in the US as Tylenol, could cause autism, insisting “science is never settled” and he would never “side with” medical experts.

The Reform UK leader said he had “no idea” if the US president was right to tell pregnant women to avoid taking acetaminophen, also known as Tylenol and paracetamol, and suggesting that those who could not “tough it out” should limit their intake.

Scientists and global health agencies including the World Health Organization have strongly dismissed Trump’s false claims, calling them misguided and saying the evidence linking paracetamol use in pregnancy and autism was “inconsistent”.

The UK’s health secretary, Wes Streeting, told the British public they should not “pay any attention whatsoever to what Donald Trump says about medicine”, adding: “I trust doctors over President Trump frankly, on this.”

But in a wide-ranging interview with LBC’s Nick Ferrari, Farage was asked directly if Trump was right to share those unproven claims. He said: “I have no idea, I’ve no idea. You know we were told thalidomide was a very safe drug and it wasn’t. Who knows Nick, I don’t know.

Advertisement

“He [Trump] has a particular thing about autism. I think because there’s been some in his family, he feels it very personally. I’ve no idea.”

When Farage was asked if he would side with medical experts who say it is dangerous to make the link, he added: “I wouldn’t. I wouldn’t. When it comes to science, I don’t side with anybody, right? You know? I don’t side with anybody, because science is never settled. We should remember that.”

Yet when challenged over whether it was irresponsible for Trump to make such an unproven claim, Farage said: “That’s an opinion he’s [Trump’s] got. It’s not one that I necessarily share.”

Farage’s refusal to condemn Trump’s claims comes weeks after a controversial doctor, Aseem Malhotra, was given top billing at Reform UK’s party conference and used his main-stage speech to claim the Covid vaccine caused cancer in the royal family. Malhotra is an adviser to Trump’s health secretary, Robert F Kennedy.

In the same interview, Farage said Trump was “right to say” that sharia law “is an issue in London”.

Advertisement

“Never take what he [Trump] says literally, ever on anything. But always take everything he says seriously,” Farage said, adding: Trump “has a point.”

“So is he right to say that sharia is an issue in London? Yes. Is it an overwhelming issue at this stage? No. Has the mayor of London directly linked himself to it? No.”

Labour MPs have urged Keir Starmer to reprimand Trump’s administration after the US president falsely claimed in a speech to the United Nations: “I look at London, where you have a terrible mayor, terrible, terrible mayor, and it’s been changed, it’s been so changed.

skip past newsletter promotion

“Now they want to go to sharia law. But you are in a different country, you can’t do that.”

Trump has been publicly attacking the London mayor, Sadiq Khan, since 2015 when the Labour politician criticised Trump, the then presidential candidate, for suggesting that Muslims should be banned from travelling to the US.

A spokesperson for Khan said: “We are not going to dignify his appalling and bigoted comments with a response. London is the greatest city in the world, safer than major US cities and we’re delighted to welcome the record number of US citizens moving here.”

During the LBC phone-in, Farage also said Reform’s plan to ban anyone who was not a UK citizen from claiming benefits would not apply to Ukrainians and Hongkongers.

Advertisement

“No, because they come for different reasons,” Farage said, adding those who had lived in the UK on indefinite leave to remain and had not worked or paid into the system would be told their benefits would be cut.

Continue Reading

News

Alphabet market value exceeds $3tn

Published

on

Alphabet market value exceeds tn

Unlock the Editor’s Digest for free

Alphabet’s market capitalisation surged above $3tn for the first time on Monday on the back of a sharp rally for the search giant’s shares over the past few weeks.

Shares in Google’s parent company have climbed more than 30 per cent to a record high of $252 since the group posted double-digit growth in revenue and profit in quarterly results out in late July.

The rally means Alphabet joins Nvidia, Microsoft and Apple as the only US companies valued above $3tn. Chipmaker Nvidia in July became the first company to hit a $4tn market value.

Advertisement

This is a developing story

Continue Reading
Advertisement

Trending